Agarwal Anil K, Zhou Xin J, Hall Roger K, Nicholls Kathy, Bankier Agnes, Van Esch Hilde, Fryns Jean-Pierre, Garg Abhimanyu
From the Division of Nutrition and Metabolic Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390-9052, USA.
J Investig Med. 2006 May;54(4):208-13. doi: 10.2310/6650.2006.05068.
Mandibuloacral dysplasia (MAD) is a rare autosomal recessive disorder characterized by skeletal abnormalities such as hypoplasia of the mandible and clavicles and acro-osteolysis. Other features include cutaneous atrophy and lipodystrophy. Two genetic loci are known for MAD: lamin A/C (LMNA), encoding structural nuclear lamina proteins, and zinc metalloproteinase (ZMPSTE24), a membrane-bound endoprotease involved in post-translational proteolytic cleavage of carboxy terminal residues of prelamin A to form mature lamin A.
Mutational analysis of ZMPSTE24 in an additional patient with MAD and determination of functional activity of mutant ZMPSTE24 in a yeast growth arrest pheromone diffusion (halo) assay.
We previously reported a Belgian woman with MAD who had ZMPSTE24 mutations and died of complications of chronic renal failure at the age of 27.5 years. We now report a 37-year-old Australian man with MAD who also had compound heterozygous mutations in the ZMPSTE24 gene, a null mutation, Phe361fsX379, and a missense mutation, Asn265Ser, which is partially active in the yeast complementation assay. He also developed end-stage renal disease and, despite receiving a cadaveric renal transplantation, died prematurely at the age of 37 years. Renal biopsies of both patients revealed focal segmental glomerulosclerosis, and the female patient had the collapsing variant.
These observations suggest focal segmental glomerulosclerosis as a phenotypic manifestation in patients with ZMPSTE24 deficiency.
下颌骨发育不全综合征(MAD)是一种罕见的常染色体隐性疾病,其特征为骨骼异常,如下颌骨和锁骨发育不全以及肢端骨质溶解。其他特征包括皮肤萎缩和脂肪营养不良。已知与MAD相关的两个基因位点:编码核纤层结构蛋白的核纤层蛋白A/C(LMNA),以及锌金属蛋白酶(ZMPSTE24),一种膜结合的内切蛋白酶,参与前体核纤层蛋白A羧基末端残基的翻译后蛋白水解切割以形成成熟的核纤层蛋白A。
对另一例MAD患者进行ZMPSTE24突变分析,并在酵母生长停滞信息素扩散(晕圈)试验中测定突变型ZMPSTE24的功能活性。
我们之前报道过一名患有MAD的比利时女性,她存在ZMPSTE24突变,27.5岁时死于慢性肾衰竭并发症。我们现在报道一名37岁患有MAD的澳大利亚男性,他在ZMPSTE24基因中也存在复合杂合突变,一个无效突变Phe361fsX379和一个错义突变Asn265Ser,后者在酵母互补试验中具有部分活性。他也发展为终末期肾病,尽管接受了尸体肾移植,但仍在37岁时过早死亡。两名患者的肾活检均显示局灶节段性肾小球硬化,并且该女性患者为塌陷型。
这些观察结果提示局灶节段性肾小球硬化是ZMPSTE24缺乏患者的一种表型表现。